SCHEMBL15464809

SCHEMBL15464809

COC(=O)c1cc(S(=O)(=O)Cl)c(F)cc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.42
HSD17B10 Q99714 2/20 0.39
ALDH1A1 P00352 2/20 0.39
TSHR P16473 2/20 0.39
HPGD P15428 1/20 0.39
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA9 Q16790 3/20 0.39
CA5A P35218 1/20 0.39
CDK1 P06493 1/20 0.38
KCNH2 Q12809 1/20 0.36
ABL1 P00519 1/20 0.36
KDM4E B2RXH2 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ACLY P53396 1/20 0.35
MAPT P10636 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CA12 O43570 2/20 0.35
CA7 P43166 2/20 0.35
CA14 Q9ULX7 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29835245 0.93 PKM (0.47) PKMHSD17B10ALDH1A1TSHRHPGD
SCHEMBL21865574 0.93 PKM (0.47) PKMHSD17B10ALDH1A1TSHRHPGD
SCHEMBL18982096 0.87 MAPT (0.45) ALDH1A1TSHRHPGDCA1CA2
SCHEMBL29991315 0.86 SOS1 (0.40) PKMHSD17B10ALDH1A1TSHRHPGD
SCHEMBL20449571 0.84 GAA (0.43) PKMHSD17B10ALDH1A1TSHRHPGD
SCHEMBL19682941 0.82 GAA (0.41) PKMHSD17B10ALDH1A1TSHRHPGD
SCHEMBL29628681 0.82 GAA (0.41) PKMHSD17B10ALDH1A1TSHRHPGD
SCHEMBL24928665 0.81 ALDH1A1 (0.42) PKMHSD17B10ALDH1A1TSHRHPGD
SCHEMBL3527127 0.79 CA12 (0.41) PKMALDH1A1CA1CA2CA9
SCHEMBL21623246 0.79 ALDH1A1 (0.39) ALDH1A1CA1CA2CA9CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3144300-B1 METHODS OF PRODUCING 4-CYCLOALKYLOXYBENZENESULFONAMIDES DAIICHI SANKYO CO LTD (JP) 2017-12-20 EP disclosed
US-9845313-B2 Cycloalkane derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2017-12-19 US disclosed
EP-3144300-A1 METHODS OF PRODUCING 4-CYCLOALKYLOXYBENZENESULFONAMIDES Daiichi Sankyo Company, Limited (JP) 2017-03-22 EP disclosed
US-20170001984-A1 CYCLOALKANE DERIVATIVES DAIICHI SANKYO COMPANY, LIMITED (JP) 2017-01-05 US disclosed
US-9493448-B2 Cycloalkane derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2016-11-15 US disclosed
EP-2813491-B1 CYCLOALKANE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2016-11-02 EP disclosed
EP-2813491-A1 CYCLOALKANE DERIVATIVE Daiichi Sankyo Co., Ltd. (JP) 2014-12-17 EP disclosed
US-8889741-B2 Cycloalkane derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-11-18 US disclosed
US-20140045862-A1 Cycloalkane Derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170001984-A1 CYCLOALKANE DERIVATIVES TRPV1, TRPA1, SCNN1A PKM 3793/4885HSD17B10 1408/4885ALDH1A1 718/4885
US-20140045862-A1 Cycloalkane Derivatives TRPV1, TRPA1, SCNN1A PKM 3793/4885HSD17B10 1408/4885ALDH1A1 718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.